Activ-POC - AD - Topical
ClinicalTrials.gov NCT04992546
Research payments
$1,558,704
Through program year 2024, $1,558,704 in research payments was reported against Activ-POC - AD - Topical, across 89 payments, paid by Genzyme Corporation.
- Paid by
- Genzyme Corporation
- ClinicalTrials.gov
- NCT04992546
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $12,600 | 1 |
| 2023 | Research | $79,213 | 7 |
| 2022 | Research | $1,404,925 | 74 |
| 2021 | Research | $61,966 | 7 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Lee San Antonio, TX Named on 22 payments
- Michelle Chambers Columbus, OH Named on 18 payments
- Steven Reynolds Long Beach, CA Named on 10 payments
- Terry Jones Bryan, TX Named on 7 payments
- Sady Alpizar Tampa, FL Named on 6 payments
- John Niven Miami Beach, FL Named on 6 payments
- Patricia Lee Webster, TX Named on 4 payments
- Ricardo Tan Lancaster, CA Named on 4 payments
- Elena Valor Miami, FL Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.